China Tightens Infant Formula Industry Oversight, Levels Playing Field
This article was originally published in The Tan Sheet
Executive Summary
China steps up oversight of pricing and compliance in the infant formula industry, imposing requirements similar to those for drug manufacturers. To tighten supervision, CFDA publishes new rules on manufacturing and marketing that raise standards and prohibit promotion of formula to medical institutions.
You may also be interested in...
Reckitt Expands 'OTC' Business, China Presence With Mead Johnson
Marketing Enfamil and other Mead Johnson formula and nutritional brands, says RB CEO Rakesh Kapoor, is "very much in the core of what consumer health stands for," and also immediately doubles the size of the firm's consumer business.
Reckitt Expands 'OTC' Business, China Presence With Mead Johnson
Marketing Enfamil and other Mead Johnson formula and nutritional brands, says RB CEO Rakesh Kapoor, is "very much in the core of what consumer health stands for," and also immediately doubles the size of the firm's consumer business.
Nutritionals Mean Health Care To Reckitt And A Boon For China Business
Marketing Enfamil and other Mead Johnson nutritional and formula brands, says RB CEO Rakesh Kapoor, is "very much in the core of what consumer health stands for," and also immediately doubles the size of the firm's consumer business.